A new general approach to 4-substituted-3-halo-2-quinolones
摘要:
A general procedure for the preparation of 4-substituted-3-halo-2-quinolones (halo = F, Cl, Br) utilizing 2-halo diethylphosphonoacetic acids (halo = F, Cl, Br) and o-aminophenylketones as the starting materials is described. The title compounds are obtained by an intramolecular Homer-Wadsworth-Emmons olefination of halogen-containing N-acyl-o-aminophenylketones. The transformation process is generally applicable under mild conditions. (C) 2010 Elsevier B.V All rights reserved.
A new general approach to 4-substituted-3-halo-2-quinolones
摘要:
A general procedure for the preparation of 4-substituted-3-halo-2-quinolones (halo = F, Cl, Br) utilizing 2-halo diethylphosphonoacetic acids (halo = F, Cl, Br) and o-aminophenylketones as the starting materials is described. The title compounds are obtained by an intramolecular Homer-Wadsworth-Emmons olefination of halogen-containing N-acyl-o-aminophenylketones. The transformation process is generally applicable under mild conditions. (C) 2010 Elsevier B.V All rights reserved.
[EN] HETEROCYCLE SUBSTITUTED PROPENOIC ACID DERIVATIVES AS NMDA ANTAGONISTS<br/>[FR] DERIVES D'ACIDE PROPENOIQUE SUBSTITUES PAR UN HETEROCYCLE UTILISES COMME ANTAGONISTES DE NMDA
申请人:HOECHST MARION ROUSSEL, INC.
公开号:WO1996013501A1
公开(公告)日:1996-05-09
(EN) 3-(Heterocyclic)-propenoic acid derivatives of formula (I) wherein G ia a radical chosen from the group (a), (b) or (c). These 3-(heterocyclic)-propenoic acid derivatives are useful as NMDA antagonists.(FR) Dérivés d'acide propénoique substitués en position 3 par un hétérocycle, de la formule (I), dans laquelle G représente un radical choisi entre (a), (b) et (c). Ces dérivés d'acide propénoique substitués en position 3 par un hétérocycle sont utiles comme antagonistes de N-méthyl-D-aspartate (NMDA).
以下是对英文文本的翻译:
(EN) 3-(Heterocyclic)-propenoic acid derivatives of formula (I) wherein G ia a radical chosen from the group (a), (b) or (c). These 3-(heterocyclic)-propenoic acid derivatives are useful as NMDA antagonists.
(翻译)3-(杂环基)丙二元酸衍生物,其分子式为(I),其中的G是一种来自(a)、(b)或(c)中的一个基团的单质根。
(FR) Dérivés d'acide propénoique substitués en position 3 par un hétérocycle, de la formule (I), dans laquelle G Represents un radical choisi entre (a), (b) et (c). Ces dérivés d'acide propénoique substitués en position 3 par un hétérocycle sont utiles comme antagonistes de N-méthyl-D-aspartate (NMDA).
翻译结果:
中文:
3-(杂环基)丙二元酸衍生物,其分子式为(I),其中的G是一种来自(a)、(b)或(c)中的一个基团的单质根。这些3-(杂环基)丙二元酸衍生物对N-méthyl-D-aspartate (NMDA)有用。
Synthesis and Antibacterial Activity of Novel 3-N-Substituted 1,8-Naphthyridin-2(1H)-ones
Synthesis of novel N-protected and unprotected 3-N-substituted 1,8-naphthyridin-2(1H)-ones with potential inhibiting activity of penicillin-binding protein 6 (PBP6) has been developed. The synthesis is designed around a Buchwald-Hartwig crosscoupling of various 3-bromo-6-substituted-1,8-naphthyridin-2(1H)-ones with two different functionalized anilines. According to the preliminary antibacterial evaluation, the products 9b-9d and 10b-10d have demonstrated high inhibiting activity against spore germination of Staphylococcus aureus (gram positive) and Escherichia coli (gram negative). The molecular docking procedure has denoted the probable interactions of the synthesized compounds 9b-9d and 10b-10d with the target protein.
HETEROCYCLE SUBSTITUTED PROPENOIC ACID DERIVATIVES AS NMDA ANTAGONISTS
申请人:HOECHST MARION ROUSSEL, INC.
公开号:EP0790994A1
公开(公告)日:1997-08-27
A new general approach to 4-substituted-3-halo-2-quinolones
作者:Shuai Zhao、Yan-hong He、Di Wu、Zhi Guan
DOI:10.1016/j.jfluchem.2010.01.008
日期:2010.5
A general procedure for the preparation of 4-substituted-3-halo-2-quinolones (halo = F, Cl, Br) utilizing 2-halo diethylphosphonoacetic acids (halo = F, Cl, Br) and o-aminophenylketones as the starting materials is described. The title compounds are obtained by an intramolecular Homer-Wadsworth-Emmons olefination of halogen-containing N-acyl-o-aminophenylketones. The transformation process is generally applicable under mild conditions. (C) 2010 Elsevier B.V All rights reserved.